Avant and Johnson & Johnson are active in the diabetes treatment industry.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Avant and Johnson & Johnson are active in the diabetes treatment industry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Avant
company
Nothing else this week.
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- United Therapeutics and Johnson & Johnson are both included in various healthcare Exchange Traded Funds (ETFs).
- Nvidia, Coca-Cola, and Johnson & Johnson are being discussed together in the context of investment trends.
- Johnson & Johnson operates a business unit focused on surgical and orthopedic equipment.
- Johnson & Johnson, Carl Zeiss, and Bausch Health are major players in the vision care market, supported by supportive government initiatives.
Coverage
Newest first; wire copies grouped- CNW GroupArtificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity MarketNewsUpdates News Commentary NEW YORK, July 22, 2025 /CNW/ -- According to a